Background Experimental studies and small clinical trials have suggested that treatment with
intranasal oxytocin may reduce social impairment in persons with autism spectrum disorder…

A role for immunological involvement in autism spectrum disorder (ASD) has long been
hypothesized. This review includes four sections describing (1) evidence for a relationship …

Rationale Individuals with autistic disorder (autism) frequently exhibit significant irritability
marked by severe tantrums, aggression, and self-injury. Despite advances in the treatment of …

Rationale Fragile X syndrome (FXS) is the most common inherited form of developmental
disability and most common single gene cause of autism. Persons with FXS frequently exhibit …

Glutamatergic dysfunction is implicated in the pathophysiology of fragile X syndrome (FXS).
We report on the first trial of acamprosate, a drug with putative mGluR5 antagonism, in three …

An immune-mediated subtype of autism spectrum disorder (ASD) has long been hypothesized.
This article reviews evidence from family history studies of autoimmunity, immunogenetics…

To date, placebo-controlled drug trials targeting the core social impairment of autistic disorder
(autism) have had uniformly negative results. Given this, the search for new potentially …

Glutamatergic dysfunction is implicated in the pathophysiology of fragile X syndrome (FXS).
The purpose of this pilot study was to examine the effectiveness and tolerability of …

This study was a 10-week double-blind, placebo-controlled pilot trial of mirtazapine for anxiety
in youth with autism spectrum disorder (ASD). Participants were ages 5 to 17 years with …

Research associating the increased prevalence of familial autoimmunity with neuropsychiatric
disorders is reliant upon the ascertainment of history of autoimmune diseases from …